Your browser doesn't support javascript.
loading
The coexistence of MET over-expression and an EGFR T790M mutation is related to acquired resistance to EGFR tyrosine kinase inhibitors in advanced non-small cell lung cancer.
Gou, Lan-Ying; Li, An-Na; Yang, Jin-Ji; Zhang, Xu-Chao; Su, Jian; Yan, Hong-Hong; Xie, Zhi; Lou, Na-Na; Liu, Si-Yang; Dong, Zhong-Yi; Gao, Hong-Fei; Zhou, Qing; Zhong, Wen-Zhao; Xu, Chong-Rui; Wu, Yi-Long.
Affiliation
  • Gou LY; Southern Medical University, Guangzhou, Guangdong, People's Republic of China.
  • Li AN; Guangdong Lung Cancer Institute, Guangdong General Hospital and Guangdong Academy of Medical Sciences, Guangzhou, People's Republic of China.
  • Yang JJ; Guangdong Lung Cancer Institute, Guangdong General Hospital and Guangdong Academy of Medical Sciences, Guangzhou, People's Republic of China.
  • Zhang XC; Guangdong Lung Cancer Institute, Guangdong General Hospital and Guangdong Academy of Medical Sciences, Guangzhou, People's Republic of China.
  • Su J; Guangdong Lung Cancer Institute, Guangdong General Hospital and Guangdong Academy of Medical Sciences, Guangzhou, People's Republic of China.
  • Yan HH; Guangdong Lung Cancer Institute, Guangdong General Hospital and Guangdong Academy of Medical Sciences, Guangzhou, People's Republic of China.
  • Xie Z; Guangdong Lung Cancer Institute, Guangdong General Hospital and Guangdong Academy of Medical Sciences, Guangzhou, People's Republic of China.
  • Lou NN; Guangdong Lung Cancer Institute, Guangdong General Hospital and Guangdong Academy of Medical Sciences, Guangzhou, People's Republic of China.
  • Liu SY; Guangdong Lung Cancer Institute, Guangdong General Hospital and Guangdong Academy of Medical Sciences, Guangzhou, People's Republic of China.
  • Dong ZY; Guangdong Lung Cancer Institute, Guangdong General Hospital and Guangdong Academy of Medical Sciences, Guangzhou, People's Republic of China.
  • Gao HF; Guangdong Lung Cancer Institute, Guangdong General Hospital and Guangdong Academy of Medical Sciences, Guangzhou, People's Republic of China.
  • Zhou Q; Guangdong Lung Cancer Institute, Guangdong General Hospital and Guangdong Academy of Medical Sciences, Guangzhou, People's Republic of China.
  • Zhong WZ; Guangdong Lung Cancer Institute, Guangdong General Hospital and Guangdong Academy of Medical Sciences, Guangzhou, People's Republic of China.
  • Xu CR; Guangdong Lung Cancer Institute, Guangdong General Hospital and Guangdong Academy of Medical Sciences, Guangzhou, People's Republic of China.
  • Wu YL; Guangdong Lung Cancer Institute, Guangdong General Hospital and Guangdong Academy of Medical Sciences, Guangzhou, People's Republic of China.
Oncotarget ; 7(32): 51311-51319, 2016 Aug 09.
Article in En | MEDLINE | ID: mdl-27259997
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Drug Resistance, Neoplasm / Proto-Oncogene Proteins c-met / Mutation, Missense / Protein Kinase Inhibitors / ErbB Receptors / Lung Neoplasms Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Oncotarget Year: 2016 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Drug Resistance, Neoplasm / Proto-Oncogene Proteins c-met / Mutation, Missense / Protein Kinase Inhibitors / ErbB Receptors / Lung Neoplasms Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Oncotarget Year: 2016 Type: Article